<DOC>
	<DOCNO>NCT00111085</DOCNO>
	<brief_summary>The purpose study measure effective safe three different dos drug clazosentan prevent vasospasm subarachnoid hemorrhage .</brief_summary>
	<brief_title>Clazosentan Preventing Occurrence Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage ( aSAH )</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Vasospasm , Intracranial</mesh_term>
	<criteria>Female patient age 18 70 year ( inclusive ) male patient age 45 70 ( inclusive ) male age 18 44 ( inclusive ) surgically naturally sterile personally sign core Informed Consent Patients rupture saccular aneurysm confirm digital subtraction angiography ( DSA ) clip coil ( endovascular obliteration ) possible . Patients diffuse localized thick subarachnoid clot baseline CT scan . Start screen within 48 hour post onset aSAH clinical symptom . WFNS Grades IIV , Grade V patient improve Grade IV less ventriculostomy . Patients SAH due cause ( e.g. , trauma rupture fusiform mycotic aneurysm ) Patients intraventricular intracerebral blood , absence subarachnoid blood . No visualized clot presence localize thin clot CT Presence degree cerebral vasospasm screen angiogram</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>aneurysmal subarachnoid hemorrhage ( aSAH )</keyword>
	<keyword>vasospasm</keyword>
	<keyword>delay ischemic neurological deficit ( DIND )</keyword>
	<keyword>computer tomography scan ( CT scan )</keyword>
	<keyword>digital subtraction angiography ( DSA )</keyword>
	<keyword>endothelin A receptor</keyword>
	<keyword>clazosentan</keyword>
</DOC>